Retigabine

Introduction Product Name Retigabine CAS No. 150812-12-7 Synonyms Ezogabine; Retigabin; N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester; Ethyl [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]carbamate; 2-Amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzene Molecular Formula C16H18FN3O2 Molecular Weight 303.33 MDL MFCD04307735 InChI 1/C16H18FN3O2/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11/h3-9,19H,2,10,18H2,1H3,(H,20,21) Appearance White or almost white powder Property* Purity 99 % Melting Point 138-140 °C Boiling Point (760 mmHg) 430 °C Density 1.307 g/cm3 Flash Point 213.9 °C *The values provided are general information and not part of the product specification. Application Main Applications Retigabine is an anticonvulsant used as an adjunctive treatment for partial epilepsies in treatment-experienced adult patients. Packaging and Handling Grade Pharma Grade Packaging According to customer's request Storage and Transportation Storage in original sealed container. Recommended storage temperature: -20 °C. Protect from moisture, heat and foreign material.
anticonvulsant

CAS NO:150812-12-7

EC NO:

Molecular Formula:C₁₆H₁₈FN₃O₂

Molecular Weight:303.3314

Synonyms:;2-AMINO-4-(4-FLUORBENZYLAMINO)-1-ETHOXYCARBONYLAMINOBENZENE; D2312;N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic Acid Ethyl Ester;D 23129;Retigabin;Ethyl [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]carbamate;RetigabineDiscontinued See: R189051;ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate;Ezogabine;

Molecular Structure: